Marc Roth, MD

Dr. Marc Roth is a gastrointestinal oncologist at Saint Luke's Cancer Institute (SLCI) in Kansas City. He completed his medical school training at the University of Kansas, followed by residency and fellowship at Vanderbilt University Medical Center in Nashville, TN. He is currently serving as the Medical Director of Gastrointestinal Oncology and Interim Chief of Oncology at SLCI. He is interested in the gaining momentum of precision medicine within GI malignancies, trial development and how the gut microbiome influences treatment outcomes.
Financial relationships
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:Total HealthTopic:SpeakerDate added:11/15/2024Date updated:11/15/2024Relationship end date:08/03/2024
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:AstrazenecaTopic:AdvisorDate added:11/15/2024Date updated:11/15/2024Relationship end date:05/24/2024
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:TakedaTopic:AdvisorDate added:11/15/2024Date updated:11/15/2024Relationship end date:04/25/2024
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:TempusTopic:AdvisorDate added:11/15/2024Date updated:11/15/2024Relationship end date:08/01/2023